Evidence for early mitogenic stimulation of metabolic flux through phosphoribosyl pyrophosphate into nucleotides in Swiss 3T3 cells.
Various mitogens activate purine and pyrimidine de novo biosynthesis and purine base phosphoribosylation as an early response in quiescent fibroblasts. Increased synthesis of 5-phosphoribosyl 1-pyrophosphate (PRPP) may precede or underlie these activations, but little direct evidence has been presented for this notion, due to lack of suitable analytical methods. To preferentially label intracellular ribose phosphate and quantitatively follow metabolic flux through PRPP into nucleotides, we prepared [ribosyl-14C]inosine and used it as a tracer. Evidence showed the validity of this method. Prior exposure of quiescent Swiss 3T3 cells in culture to epidermal growth factor plus insulin for 45-60 min enhanced approximately 2-fold the radioactivity incorporation from [ribosyl-14C]inosine into nucleotides, without increasing the specific radioactivity of intracellular free ribose 5-phosphate. [14C]Uracil incorporation into nucleotides, a measure of PRPP-independent ribose phosphate utilization for nucleotide synthesis, was not increased. These and other results indicate that epidermal growth factor plus insulin stimulates the metabolic flux through PRPP. Similar extents of stimulation were induced by bombesin and melittin in combination with insulin and by fibroblast growth factor alone, suggesting the presence of an unknown signaling pathway common to these mitogens. This system is highly useful for studies of the mechanisms that stimulate in situ activity of PRPP synthetase.
Ishijima
S
S
Department of Biochemistry, Chiba University School of Medicine.
Kita
K
K
Kinoshita
N
N
Ishizuka
T
T
Suzuki
N
N
Tatibana
M
M
D000818:Animals; D001514:Bee Venoms / Q000008:administration & dosage*; D001839:Bombesin / Q000008:administration & dosage; D002250:Carbon Radioisotopes; D002417:Cattle; D004789:Enzyme Activation; D004815:Epidermal Growth Factor / Q000494:pharmacology; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D008555:Melitten / Q000008:administration & dosage*; D051379:Mice; D008934:Mitogens / Q000008:administration & dosage*; D009711:Nucleotides / Q000096:biosynthesis; D010428:Pentosephosphates / Q000096:biosynthesis*; D010754:Phosphoribosyl Pyrophosphate / Q000096:biosynthesis*; D012268:Ribose-Phosphate Pyrophosphokinase / Q000378:metabolism; D013268:Stimulation, Chemical
D001514:Bee Venoms; D002250:Carbon Radioisotopes; D007328:Insulin; D008934:Mitogens; D009711:Nucleotides; D010428:Pentosephosphates; D008555:Melitten; D004815:Epidermal Growth Factor; D010754:Phosphoribosyl Pyrophosphate; D012268:Ribose-Phosphate Pyrophosphokinase; D001839:Bombesin